Form ARS Allogene Therapeutics, For: Dec 31
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ITG, Inc. Announces Launch of Initial Public Offering
- Valens Semiconductor Appoints Karine Pinto-Flomenboim as Chief Financial Officer
- Ennis, Inc. Reports Results for the Quarter Ended May 31, 2026 and Declares Quarterly Dividend
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
